APA (7th ed.) Citation

Escobar, C., Barrios, V., Lip, G. Y. H., Amin, A. N., Auladell-Rispau, A., Santero, M., . . . Requeijo, C. (2021). Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. Clinical Drug Investigation, 41(11), 941. https://doi.org/10.1007/s40261-021-01091-w

Chicago Style (17th ed.) Citation

Escobar, Carlos, Vivencio Barrios, Gregory Y. H. Lip, Alpesh N. Amin, Ariadna Auladell-Rispau, Marilina Santero, Josefina Salazar, and Carolina Requeijo. "Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis." Clinical Drug Investigation 41, no. 11 (2021): 941. https://doi.org/10.1007/s40261-021-01091-w.

MLA (9th ed.) Citation

Escobar, Carlos, et al. "Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis." Clinical Drug Investigation, vol. 41, no. 11, 2021, p. 941, https://doi.org/10.1007/s40261-021-01091-w.